Showing results (41-50 of 107) with videos related to
Sort By:
Pageof 11
Glycobiology|December 27, 2005
A defect in exodegradative pathways provides insight into endodegradation of heparan and dermatan sulfatesMaria Fuller, Ally Chau, Rachael C Nowak, et al.Molecular Genetics and Metabolism|December 4, 2014
Absence of α-galactosidase cross-correction in Fabry heterozygote cultured skin fibroblastsMaria Fuller, Natalie Mellett, Leanne K Hein, et al.Analytical Biochemistry|April 29, 2014
Liquid chromatography/electrospray ionisation-tandem mass spectrometry quantification of GM2 gangliosides in human peripheral cells and plasmaMaria Fuller, Stephen Duplock, Leanne K Hein, et al.Experimental Neurology|December 30, 2015
Selective normalisation of regional brain bis(monoacylglycero)phosphate in the mucopolysaccharidosis 1 (Hurler) mouseJennifer T Saville, Rebecca J Lehmann, Ainslie L K Derrick-Roberts, et al.Pediatric Research|September 7, 2004
Disease-specific markers for the mucopolysaccharidosesMaria Fuller, Tina Rozaklis, Steven L Ramsay, et al.Clinical Chemistry and Laboratory Medicine|August 24, 2022
Free urinary sialic acid levels may be elevated in patients with pneumococcal sepsisSarah E Donoghue, Oliver Heath, James Pitt, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 5, 2005
Laronidase treatment of mucopolysaccharidosis IEd J Wraith, John J Hopwood, Maria Fuller, et al.Journal of Inherited Metabolic Disease|November 11, 2019
Expanding the clinical utility of glucosylsphingosine for Gaucher diseaseJennifer T Saville, Belinda K McDermott, Sharon J Chin, et al.Blood Cells, Molecules & Diseases|May 7, 2013
Transgenic mice expressing human glucocerebrosidase variants: utility for the study of Gaucher diseaseAngela Sanders, Harmony Hemmelgarn, Heather L Melrose, et al.Biochemical and Biophysical Research Communications|October 4, 2016
Drug induced exocytosis of glycogen in Pompe diseaseChristopher T Turner, Maria Fuller, John J Hopwood, et al.Pageof 11